Seattle Treatment Education Project

Trials at Swedish Medical Center

December 30, 2003

Tipranavir Early Access Program

There are limited openings in this program. Please contact Healther Algren at (206) 386-2820.

Protease Inhibitor Study

You may be eligible to join a research study of a medication for HIV disease if you have taken HIV medications in the past that no longer work for you and you are currently taking a combination of HIV medications and your viral load is over 1,000 copies. Please contact Janice Price at (206) 386-2523.

Back to the STEP Ezine Volume 1, Issue 53 contents page.

This article was provided by Seattle Treatment Education Project. It is a part of the publication STEP Ezine.

Read More About Washington

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

OIs and Co-Infections and STIs -- Oh, My!

World AIDS Day 2009: Home

HIV Antiretrovirals in Development: An Update From ICAAC 2009

Back From the Brink: A Blog Entry by Thomas DeLorenzo

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.